Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter's Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis0q
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1 DROC
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
Chapter 5 Market Segmentation Analysis
Chapter 6 Market Segmentation by Product
6.1 Introduction
6.2 Cell-based products
6.2.1 Allogeneic products
6.2.2 Autologous products
6.3 Acellular products
Chapter 7 Market Segmentation by Application
7.1 Introduction
7.2 Orthopaedic and musculoskeletal disorders
7.3 Dermatology
7.4 Cardiology
7.5 Central nervous system diseases
7.6 Oncology
7.7 Diabetes
7.8 Bone graft substitutes
7.9 Others
Chapter 8 Market Segmentation by Therapy
8.1 Introduction
8.2 Cell therapy
8.3 Immunotherapy
8.4 Tissue therapy
8.5 Gene therapy
8.6 Others
Chapter 9 Market Segmentation by Material
9.1 Introduction
9.2 Algae-derived alginate
9.3 Synthetic polymer
9.4 Poly-lactide-coglycolide
9.5 Poly-ethylene glycol
9.6 Hydrogels
9.7 Others
Chapter 10 Market Segmentation by Agent type
10.1 Introduction
10.2 Biologics
10.2.1 Autologous fibroblasts
10.2.2 Hematopoietic stem and progenitor cells
10.3 Cell-based medical devices
10.3.1 Allogenic fibroblasts
10.3.2 Cell extraction
10.4 Biopharmaceuticals
10.4.1 Tricalcium phosphate
10.4.2 Osteogenic protein
Chapter 11 Market Segmentation by Geography
11.1 Europe
11.1.1 Introduction
11.1.2 France
11.1.3 Germany
11.1.4 Italy
11.1.5 United Kingdom
11.1.6 Spain
11.1.7 Russia
11.1.8 Others
Chapter 12 Competitive Landscape
12.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
12.2 Market Share Analysis
12.3 Strategies Adopted By Top Companies
Chapter 13 Company Profiles
13.1 Depuy Synthes, Inc.
13.2 Baxter International, Inc.
13.3 Smith & Nephew Plc
13.4 Anika Therapeutics, Inc.
13.4 Zimmer Holdings, Inc.
13.5 Conmed Corporation
13.6 Arthrex, Inc.
13.7 Stryker Corporation
13.8 Medtronic, Inc.
13.9 Kinetic Concepts, Inc.
13.10 Genzyme
13.11 Cytori Therapeutics
13.12 Mesoblast
Chapter 14 Market Insights
14.1 Insights of Industry Experts
14.2 Analyst Opinion (Market Understanding)
14.3 Investment Opportunities
Chapter 15 Appendix
15.1 List of Tables
15.2 List of Figures
